Pricing Log in Create free account

GlucoTrack, Inc. (GCTK) vs NexGel, Inc. (NXGL)

GlucoTrack, Inc. and NexGel, Inc. are both Medical Instruments & Supplies companies. NexGel, Inc. is the larger, with a market value of $15.9M against $840.0K — 19.0× the size. NexGel, Inc. grew revenue faster over the last twelve months: 3.38% against −60.6%. GlucoTrack, Inc. has the higher net margin (0.00% vs −51.3%) and the higher return on invested capital (0.00% vs −45.3%). Across the 17 metrics below, NexGel, Inc. leads on 9 and GlucoTrack, Inc. on 8.

Valuation

Metric GCTK NXGL Medical Instruments & Supplies median
P/E n/m n/m 33.75
P/S 1.17 4.18 2.52
P/B n/m 9.22 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA n/m n/m 14.62
EV/Sales 5.10 4.35 2.88
Earnings yield (18,853.56%) (12.70%) (2.67%)
Free cash flow yield (6,690.23%) (6.63%) 0.09%

Profitability

Metric GCTK NXGL Medical Instruments & Supplies median
Gross margin 0.00% 35.08% 54.29%
Operating margin 0.00% (44.77%) 1.07%
Net margin 0.00% (51.26%) (1.61%)
Free cash flow margin 0.00% (27.66%) 1.08%
Return on equity (620.63%) (117.57%) (1.32%)
Return on assets (272.48%) (34.21%) 0.00%
Return on invested capital 0.00% (45.29%) 0.00%

Growth

Metric GCTK NXGL Medical Instruments & Supplies median
Revenue growth (TTM) (60.61%) 3.38% 8.85%
EPS growth (last fiscal year) 99.24% 24.00% 8.65%
Revenue growth, 5-year CAGR 28.31% 76.12% 9.17%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GCTK NXGL Medical Instruments & Supplies median
Debt to equity (1.11) 0.68 0.10
Current ratio 0.46 0.43 2.48
Net debt to EBITDA 0.25 0.13 0.89

Dividend

Metric GCTK NXGL Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric GCTK NXGL Medical Instruments & Supplies median
Market cap 840.00k 15.92m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack